CD14 and chronic kidney disease: Lipopolysaccharide (LPS)-induced expression of lymphocyte co-stimulating CD40, CD80, and CD86 remains mitigated when CD14+ monocytes from CKD patients are consecutively cultivated under non-uremic condition and LPS effects on co-stimulatory molecule expression remain absent in uremic media [76].